Lymph Node Transfer and Neolymphangiogenesis: From Theory to Evidence

Area of Science:

• Vascular Surgery
• Regenerative Medicine
• Lymphedema Research

Background:

• Vascularized lymph node transfer (VLNT) is a key treatment for advanced lymphedema.
• The mechanism of VLNT's efficacy, particularly neolymphangiogenesis, requires further biological validation.
• This study investigates lymphatic vessel formation post-VLNT.

Purpose of the Study:

• To provide histologic evidence of new lymphatic vessel formation after VLNT.
• To demonstrate the induction of neolymphangiogenesis in lymphedematous limbs following VLNT.
• To correlate lymphatic vessel density with clinical outcomes.

Main Methods:

• Retrospective analysis of 14 patients undergoing gastroepiploic VLNT for extremity lymphedema.
• Histologic analysis of skin biopsy specimens from lymphedematous limbs at baseline (T0) and 1-year follow-up (T1).
• Immunohistochemical staining for lymphatic endothelial markers (podoplanin/gp36) to quantify lymphatic vessel density.

Main Results:

• Significant reduction in limb circumference observed at 12 months post-VLNT.
• Mean lymphatic vessel density increased from 7.92 vessels/mm² at T0 to 11.79 vessels/mm² at T1 (P = 0.0008).
• Increased lymphatic vessel formation was detected near the transferred lymph nodes.

Conclusions:

• VLNT induces a neolymphangiogenic process in lymphedematous limbs.
• Histologic evidence supports the formation of new, functional lymphatic vessels after VLNT.
• These findings provide a biological basis for the clinical success of VLNT in lymphedema management.